Citation tools
"Comparative cost-effectiveness of three strategies for guiding second-line erlotinib initiation in non small-cell lung cancer: a French prospective multicenter study (ERMETIC Project Part 3)." European Respiratory Journal
(2011):
erj02012-2010.
Web. 12 Dec. 2024.